Published in Future Oncol on September 01, 2010
Trichomonosis, a common curable STI, and prostate carcinogenesis--a proposed molecular mechanism. PLoS Pathog (2012) 1.10
Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cells. Oncogene (2011) 1.02
PIM kinase inhibitor AZD1208 for treatment of MYC-driven prostate cancer. J Natl Cancer Inst (2014) 0.90
Pim Kinase Interacts with Nonstructural 5A Protein and Regulates Hepatitis C Virus Entry. J Virol (2015) 0.86
MicroRNA-101-3p suppresses cell proliferation, invasion and enhances chemotherapeutic sensitivity in salivary gland adenoid cystic carcinoma by targeting Pim-1. Am J Cancer Res (2015) 0.86
A small-molecule inhibitor of PIM kinases as a potential treatment for urothelial carcinomas. Neoplasia (2014) 0.86
Inhibition of oncogenic Pim-3 kinase modulates transformed growth and chemosensitizes pancreatic cancer cells to gemcitabine. Cancer Biol Ther (2013) 0.85
PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer. Nat Med (2016) 0.85
PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma. Oncotarget (2015) 0.84
The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells. Oncogene (2015) 0.81
Pim-1: A new biomarker in pulmonary arterial hypertension. Pulm Circ (2013) 0.81
Expression of pim-1 in tumors, tumor stroma and tumor-adjacent mucosa co-determines the prognosis of colon cancer patients. PLoS One (2013) 0.80
Pim-1 acts as an oncogene in human salivary gland adenoid cystic carcinoma. J Exp Clin Cancer Res (2014) 0.79
PIM-1 modulates cellular senescence and links IL-6 signaling to heterochromatin formation. Aging Cell (2014) 0.79
PIM kinases as therapeutic targets against advanced melanoma. Oncotarget (2016) 0.78
RNAi screen identifies a synthetic lethal interaction between PIM1 overexpression and PLK1 inhibition. Clin Cancer Res (2014) 0.78
Pim-1 kinase as cancer drug target: An update. Biomed Rep (2015) 0.77
Design and Synthesis of Potent and Selective PIM Kinase Inhibitors by Targeting Unique Structure of ATP-Binding Pocket. ACS Med Chem Lett (2017) 0.75
Targeting of glioblastoma cell lines and glioma stem cells by combined PIM kinase and PI3K-p110α inhibition. Oncotarget (2016) 0.75
PIM1 polymorphism and PIM1 expression as predisposing factors of esophageal squamous cell carcinoma in the Asian population. Onco Targets Ther (2016) 0.75
Identification of quinones as novel PIM1 kinase inhibitors. Bioorg Med Chem Lett (2016) 0.75
PIM1: a promising target in patients with triple-negative breast cancer. Med Oncol (2017) 0.75
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature (1988) 14.66
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (1990) 14.46
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med (1996) 13.49
Delineation of prognostic biomarkers in prostate cancer. Nature (2001) 12.25
Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell (1995) 8.75
Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science (1997) 8.17
Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell (2003) 6.38
3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase. Curr Biol (1997) 5.66
Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region. Cell (1984) 5.56
Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J Cell Sci (2003) 5.26
ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nat Cell Biol (2008) 5.19
Cell cycle and death control: long live Forkheads. Trends Biochem Sci (2002) 4.87
Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin (2010) 4.76
The p53-Mdm2 module and the ubiquitin system. Semin Cancer Biol (2003) 4.46
Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc Natl Acad Sci U S A (1998) 4.38
The myeloproliferative disorders. N Engl J Med (2006) 4.30
Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene (2002) 4.15
Determination of the specific substrate sequence motifs of protein kinase C isozymes. J Biol Chem (1997) 3.86
The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor. Genes Dev (2003) 3.79
Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors. Cell (1989) 3.31
PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation. Nat Cell Biol (2007) 3.26
Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood (1993) 2.96
Bcl-XL and Bcl-2 repress a common pathway of cell death. J Exp Med (1995) 2.94
MDM2, an introduction. Mol Cancer Res (2003) 2.87
Akt activation promotes degradation of tuberin and FOXO3a via the proteasome. J Biol Chem (2003) 2.80
Activation of protein kinase B beta and gamma isoforms by insulin in vivo and by 3-phosphoinositide-dependent protein kinase-1 in vitro: comparison with protein kinase B alpha. Biochem J (1998) 2.73
Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site. FEBS Lett (2004) 2.65
The survival kinases Akt and Pim as potential pharmacological targets. J Clin Invest (2005) 2.62
Structural basis of inhibitor specificity of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM-1) kinase. J Med Chem (2005) 2.34
The serine/threonine kinase Pim-1. Int J Biochem Cell Biol (2005) 2.32
Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors. Mol Cell Biol (2004) 2.31
Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis. Immunity (1999) 2.31
Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels. Cancer Res (2008) 2.20
Regulation of pim and myb mRNA accumulation by interleukin 2 and interleukin 3 in murine hematopoietic cell lines. J Biol Chem (1988) 2.19
Transcriptome analysis of microdissected pancreatic intraepithelial neoplastic lesions. Oncogene (2005) 2.14
Mice bearing the E mu-myc and E mu-pim-1 transgenes develop pre-B-cell leukemia prenatally. Mol Cell Biol (1991) 2.06
Janus kinases: components of multiple signaling pathways. Oncogene (2000) 2.02
Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: role of Stat5 in proliferation. EMBO J (1996) 2.02
The Pim kinases control rapamycin-resistant T cell survival and activation. J Exp Med (2005) 1.99
Hypoxia-inducible proto-oncogene Pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma. Cancer Biol Ther (2008) 1.95
Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study. Leuk Lymphoma (2008) 1.91
Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis. J Vet Sci (2001) 1.89
The biological functions of A-kinase anchor proteins. J Mol Biol (2001) 1.88
Pim-1 is up-regulated by constitutively activated FLT3 and plays a role in FLT3-mediated cell survival. Blood (2004) 1.86
Phosphorylation of the cell cycle inhibitor p21Cip1/WAF1 by Pim-1 kinase. Biochim Biophys Acta (2002) 1.86
Pim kinase-dependent inhibition of c-Myc degradation. Oncogene (2008) 1.85
Physical and functional interactions between Pim-1 kinase and Cdc25A phosphatase. Implications for the Pim-1-mediated activation of the c-Myc signaling pathway. J Biol Chem (1999) 1.83
PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers. Haematologica (2010) 1.83
Structural basis of constitutive activity and a unique nucleotide binding mode of human Pim-1 kinase. J Biol Chem (2004) 1.80
Crystal structures of proto-oncogene kinase Pim1: a target of aberrant somatic hypermutations in diffuse large cell lymphoma. J Mol Biol (2005) 1.79
Signaling through protein kinase C. Front Biosci (1998) 1.78
Growth factors inactivate the cell death promoter BAD by phosphorylation of its BH3 domain on Ser155. J Biol Chem (2000) 1.74
ASK1 mediates apoptotic cell death induced by genotoxic stress. Oncogene (1999) 1.70
Potential roles for the PIM1 kinase in human cancer - a molecular and therapeutic appraisal. Eur J Cancer (2008) 1.65
Structural analysis identifies imidazo[1,2-b]pyridazines as PIM kinase inhibitors with in vitro antileukemic activity. Cancer Res (2007) 1.62
Pim serine/threonine kinases regulate the stability of Socs-1 protein. Proc Natl Acad Sci U S A (2002) 1.61
Pim-1 kinase-dependent phosphorylation of p21Cip1/WAF1 regulates its stability and cellular localization in H1299 cells. Mol Cancer Res (2007) 1.59
The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway. Oncogene (1999) 1.59
Proviral tagging in E mu-myc transgenic mice lacking the Pim-1 proto-oncogene leads to compensatory activation of Pim-2. EMBO J (1995) 1.55
The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells. EMBO J (2002) 1.55
The 44-kDa Pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells. J Biol Chem (2007) 1.55
Ruthenium half-sandwich complexes bound to protein kinase Pim-1. Angew Chem Int Ed Engl (2006) 1.54
T cell antigen receptor engagement stimulates c-raf phosphorylation and induces c-raf-associated kinase activity via a protein kinase C-dependent pathway. J Biol Chem (1990) 1.53
The oncogenic serine/threonine kinase Pim-1 directly phosphorylates and activates the G2/M specific phosphatase Cdc25C. Int J Biochem Cell Biol (2005) 1.50
Protein kinase Ctheta: a new essential superstar on the T-cell stage. Immunol Today (2000) 1.50
Pim-1 ligand-bound structures reveal the mechanism of serine/threonine kinase inhibition by LY294002. J Biol Chem (2005) 1.48
Pim family kinases enhance tumor growth of prostate cancer cells. Mol Cancer Res (2005) 1.46
The PIM1 kinase is a critical component of a survival pathway activated by docetaxel and promotes survival of docetaxel-treated prostate cancer cells. J Biol Chem (2008) 1.46
Protein kinase Calpha (PKCalpha) acts upstream of PKCtheta to activate IkappaB kinase and NF-kappaB in T lymphocytes. Mol Cell Biol (2003) 1.44
Overexpression of Pim-1 during progression of prostatic adenocarcinoma. J Clin Pathol (2006) 1.42
PIM-1-specific mAb suppresses human and mouse tumor growth by decreasing PIM-1 levels, reducing Akt phosphorylation, and activating apoptosis. J Clin Invest (2009) 1.41
In vivo analysis of Pim-1 deficiency. Nucleic Acids Res (1993) 1.40
Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma. Oncogene (2010) 1.39
Pim-1 associates with protein complexes necessary for mitosis. Chromosoma (2002) 1.39
Gene expression profile predicts patient survival of gastric cancer after surgical resection. J Clin Oncol (2005) 1.38
Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes. Mol Cancer Ther (2009) 1.38
M32, a murine homologue of Drosophila heterochromatin protein 1 (HP1), localises to euchromatin within interphase nuclei and is largely excluded from constitutive heterochromatin. Cytogenet Cell Genet (1996) 1.37
Overexpression of the oncogenic kinase Pim-1 leads to genomic instability. Cancer Res (2003) 1.35
Characterization of a potent and selective small-molecule inhibitor of the PIM1 kinase. Mol Cancer Ther (2007) 1.33
Effect of phosphoinositide-dependent kinase 1 on protein kinase B translocation and its subsequent activation. Mol Cell Biol (2000) 1.32
The oncogenic serine/threonine kinase Pim-1 phosphorylates and inhibits the activity of Cdc25C-associated kinase 1 (C-TAK1): a novel role for Pim-1 at the G2/M cell cycle checkpoint. J Biol Chem (2004) 1.32
Pim-1 expression in prostatic intraepithelial neoplasia and human prostate cancer. Prostate (2004) 1.31
Identification and structure-activity relationships of substituted pyridones as inhibitors of Pim-1 kinase. Bioorg Med Chem Lett (2007) 1.30
Effects of the JAK2 inhibitor, AZ960, on Pim/BAD/BCL-xL survival signaling in the human JAK2 V617F cell line SET-2. J Biol Chem (2008) 1.30
Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization. Int J Cancer (2002) 1.29
IL-3 induces a Pim1-dependent antiapoptotic pathway in primary human basophils. Blood (2008) 1.28
Developmental expression of pim kinases suggests functions also outside of the hematopoietic system. Oncogene (2000) 1.26
EPO receptor circuits for primary erythroblast survival. Blood (2008) 1.26
Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays. Mol Cell Proteomics (2009) 1.24
Pim-1 kinase stability is regulated by heat shock proteins and the ubiquitin-proteasome pathway. Mol Cancer Res (2005) 1.24
The 44 kDa Pim-1 kinase directly interacts with tyrosine kinase Etk/BMX and protects human prostate cancer cells from apoptosis induced by chemotherapeutic drugs. Oncogene (2006) 1.23
Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling. Blood (2004) 1.21
Screening of gene expression profiles in gastric epithelial cells induced by Helicobacter pylori using microarray analysis. Aliment Pharmacol Ther (2002) 1.20
CD40 signaling in B cells regulates the expression of the Pim-1 kinase via the NF-kappa B pathway. J Immunol (2002) 1.20
Pim-1 kinase inhibits STAT5-dependent transcription via its interactions with SOCS1 and SOCS3. Blood (2004) 1.19
The p21 and PCNA partnership: a new twist for an old plot. Cell Cycle (2008) 1.19
Sustained expression of the pim-1 kinase is specifically induced in myeloid cells by cytokines whose receptors are structurally related. Oncogene (1992) 1.19
Docking study yields four novel inhibitors of the protooncogene Pim-1 kinase. J Med Chem (2008) 1.18
Pim kinase substrate identification and specificity. J Biochem (2007) 1.17
Network of dynamic interactions between histone H1 and high-mobility-group proteins in chromatin. Mol Cell Biol (2004) 2.33
Periodontal ligament stem cell-mediated treatment for periodontitis in miniature swine. Stem Cells (2008) 1.99
Pim-1 kinase-dependent phosphorylation of p21Cip1/WAF1 regulates its stability and cellular localization in H1299 cells. Mol Cancer Res (2007) 1.59
The high-mobility group A1 gene up-regulates cyclooxygenase 2 expression in uterine tumorigenesis. Cancer Res (2007) 1.42
PIM-1-specific mAb suppresses human and mouse tumor growth by decreasing PIM-1 levels, reducing Akt phosphorylation, and activating apoptosis. J Clin Invest (2009) 1.41
Pim-1 associates with protein complexes necessary for mitosis. Chromosoma (2002) 1.39
Pim-1 kinase antagonizes aspects of myocardial hypertrophy and compensation to pathological pressure overload. Proc Natl Acad Sci U S A (2008) 1.31
Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome. Blood (2012) 1.27
Pim-1 kinase stability is regulated by heat shock proteins and the ubiquitin-proteasome pathway. Mol Cancer Res (2005) 1.24
Recruitment of SWI/SNF to the human immunodeficiency virus type 1 promoter. Mol Cell Biol (2004) 1.15
Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation. Oncogene (2004) 1.11
Trichomonosis, a common curable STI, and prostate carcinogenesis--a proposed molecular mechanism. PLoS Pathog (2012) 1.10
Vitamin C treatment promotes mesenchymal stem cell sheet formation and tissue regeneration by elevating telomerase activity. J Cell Physiol (2012) 1.09
Inhibition of nucleotide excision repair by high mobility group protein HMGA1. J Biol Chem (2005) 1.09
Pim-1 preserves mitochondrial morphology by inhibiting dynamin-related protein 1 translocation. Proc Natl Acad Sci U S A (2013) 1.08
Sialin (SLC17A5) functions as a nitrate transporter in the plasma membrane. Proc Natl Acad Sci U S A (2012) 1.04
Protein arginine methyltransferase 6 specifically methylates the nonhistone chromatin protein HMGA1a. Biochem Biophys Res Commun (2005) 1.03
The human IL-2 gene promoter can assemble a positioned nucleosome that becomes remodeled upon T cell activation. J Immunol (2002) 1.02
Nuclear HMGA1 nonhistone chromatin proteins directly influence mitochondrial transcription, maintenance, and function. Exp Cell Res (2006) 1.02
High-mobility group A1a protein regulates Ras/ERK signaling in MCF-7 human breast cancer cells. Oncogene (2004) 1.01
Differential effects of FR900482 and FK317 on apoptosis, IL-2 gene expression, and induction of vascular leak syndrome. Chem Biol (2002) 0.96
Acyl homoserine lactone-based quorum sensing in a methanogenic archaeon. ISME J (2012) 0.96
Functional tooth restoration by allogeneic mesenchymal stem cell-based bio-root regeneration in swine. Stem Cells Dev (2013) 0.95
Comparative understanding of UTS2 and UTS2R genes for their involvement in type 2 diabetes mellitus. Int J Biol Sci (2008) 0.92
Long-term transduction of miniature pig parotid glands using serotype 2 adeno-associated viral vectors. J Gene Med (2009) 0.91
Periodontal ligament stem cells regulate B lymphocyte function via programmed cell death protein 1. Stem Cells (2013) 0.89
Mesenchymal stem cells derived from inflamed periodontal ligaments exhibit impaired immunomodulation. J Clin Periodontol (2012) 0.88
MiR-199a suppresses the hypoxia-induced proliferation of non-small cell lung cancer cells through targeting HIF1α. Mol Cell Biochem (2013) 0.88
Metabolomics of colorectal cancer: past and current analytical platforms. Anal Bioanal Chem (2013) 0.88
Pim-2 phosphorylation of p21(Cip1/WAF1) enhances its stability and inhibits cell proliferation in HCT116 cells. Int J Biochem Cell Biol (2010) 0.88
In vivo posttranslational modifications of the high mobility group A1a proteins in breast cancer cells of differing metastatic potential. Biochemistry (2004) 0.88
Human KIT ligand promoter is positively regulated by HMGA1 in breast and ovarian cancer cells. Oncogene (2004) 0.87
Distamycin A inhibits HMGA1-binding to the P-selectin promoter and attenuates lung and liver inflammation during murine endotoxemia. PLoS One (2010) 0.86
The metabolic disturbances of isoproterenol induced myocardial infarction in rats based on a tissue targeted metabonomics. Mol Biosyst (2013) 0.86
HMGA1a: sequence-specific RNA-binding factor causing sporadic Alzheimer's disease-linked exon skipping of presenilin-2 pre-mRNA. Genes Cells (2007) 0.86
Dynamic and differential in vivo modifications of the isoform HMGA1a and HMGA1b chromatin proteins. J Biol Chem (2004) 0.85
Network pharmacology study on the mechanism of traditional Chinese medicine for upper respiratory tract infection. Mol Biosyst (2014) 0.85
HMGA1 co-activates transcription in B cells through indirect association with DNA. J Biol Chem (2003) 0.85
High-mobility group A1 proteins inhibit expression of nucleotide excision repair factor xeroderma pigmentosum group A. Cancer Res (2007) 0.85
Dynamic mitochondrial localization of nuclear transcription factor HMGA1. Exp Cell Res (2005) 0.84
Effects of fertility on gene expression and function of the bovine endometrium. PLoS One (2013) 0.84
Metabonomics Combined with UPLC-MS Chemical Profile for Discovery of Antidepressant Ingredients of a Traditional Chinese Medicines Formula, Chaihu-Shu-Gan-San. Evid Based Complement Alternat Med (2013) 0.84
Functional UQCRC1 polymorphisms affect promoter activity and body lipid accumulation. Obesity (Silver Spring) (2007) 0.84
A novel type of sequence variation: multiple-nucleotide length polymorphisms discovered in the bovine genome. Genetics (2007) 0.84
Chaetoglobins A and B, two unusual alkaloids from endophytic Chaetomium globosum culture. Chem Commun (Camb) (2008) 0.83
NMR resonance assignments of the human high mobility group protein HMGA1. J Biomol NMR (2007) 0.83
Ring-shaped corneoscleral lamellar keratoplasty guided by high-definition optical coherence tomography and Scheimpflug imaging for severe Terrien's marginal corneal degeneration. Graefes Arch Clin Exp Ophthalmol (2012) 0.83
HMGA1 drives metabolic reprogramming of intestinal epithelium during hyperproliferation, polyposis, and colorectal carcinogenesis. J Proteome Res (2015) 0.82
HMGA1 levels influence mitochondrial function and mitochondrial DNA repair efficiency. Mol Cell Biol (2009) 0.82
Integration of ¹H NMR and UPLC-Q-TOF/MS for a comprehensive urinary metabonomics study on a rat model of depression induced by chronic unpredictable mild stress. PLoS One (2013) 0.81
[Overview of application and research of Echinops genus in Chinese medicine]. Zhongguo Zhong Yao Za Zhi (2014) 0.81
Study on the anti-gout activity of chlorogenic acid: improvement on hyperuricemia and gouty inflammation. Am J Chin Med (2014) 0.81
Gene-specific nucleotide excision repair is impaired in human cells expressing elevated levels of high mobility group A1 nonhistone proteins. DNA Repair (Amst) (2007) 0.80
Epigallocatechin-3-gallate induces apoptosis, inhibits proliferation and decreases invasion of glioma cell. Neurosci Bull (2013) 0.80
Chaetochromones A and B, two new polyketides from the fungus Chaetomium indicum (CBS.860.68). Molecules (2013) 0.80
Aspirin treatment improved mesenchymal stem cell immunomodulatory properties via the 15d-PGJ2/PPARγ/TGF-β1 pathway. Stem Cells Dev (2014) 0.79
Gusanlungionosides A-D, potential tyrosinase inhibitors from Arcangelisia gusanlung. J Nat Prod (2011) 0.79
Osteogenic differentiated periodontal ligament stem cells maintain their immunomodulatory capacity. J Tissue Eng Regen Med (2012) 0.79
microRNA-21 mediates stretch-induced osteogenic differentiation in human periodontal ligament stem cells. Stem Cells Dev (2014) 0.79
Structural identification of the metabolites for strictosamide in rats bile by an ion trap-TOF mass spectrometer and mass defect filter technique. J Chromatogr B Analyt Technol Biomed Life Sci (2011) 0.78
The evaluation and implementation of Direct Analysis in Real Time quadrupole time-of-flight tandem mass spectrometry for characterization and quantification of geniposide in Re Du Ning Injections. Rapid Commun Mass Spectrom (2012) 0.78
[Phase II study of docetaxel plus epirubicin versus docetaxel plus cisplatin as first-line chemotherapy for advanced breast cancer]. Zhonghua Zhong Liu Za Zhi (2008) 0.78
Overexpression and characterization of a Ca(2+) activated thermostable β-glucosidase with high ginsenoside Rb1 to ginsenoside 20(S)-Rg3 bioconversion productivity. J Ind Microbiol Biotechnol (2015) 0.78
Re-sensitization of 5-FU resistance by SPARC through negative regulation of glucose metabolism in hepatocellular carcinoma. Tumour Biol (2014) 0.78
Two new natural products from Croton kongensis Gagnep. Nat Prod Res (2014) 0.77
Lactonecembranoids from Croton laevigatus. J Nat Prod (2010) 0.77
Characterizing metabolic changes in human colorectal cancer. Anal Bioanal Chem (2015) 0.77
An automated dual-gradient liquid chromatography-MS/MS method for the simultaneous determination of ferulic acid, ligustrazine and ligustilide in rat plasma and its application to a pharmacokinetic study. J Pharm Biomed Anal (2013) 0.77
HMGA1 enhances the transcriptional activity and binding of the estrogen receptor to its responsive element. Biochemistry (2002) 0.77
Microcrystalline preparation of akebia saponin D for its bioavailability enhancement in rats. Am J Chin Med (2015) 0.77
Netrin-1 promoted pancreatic cancer cell proliferation by upregulation of Mdm2. Tumour Biol (2014) 0.77
Voltage-dependent blockade by bupivacaine of cardiac sodium channels expressed in Xenopus oocytes. Neurosci Bull (2014) 0.77
Effect of serum from patients with severe acute pancreatitis on vascular endothelial permeability. Pancreas (2013) 0.76
Spatial and temporal expression of c-Kit in the development of the murine submandibular gland. J Mol Histol (2014) 0.76
Pharmacological kinetics of BmK AS, a sodium channel site 4-specific modulator on Nav1.3. Neurosci Bull (2012) 0.76
Signaling by intracellular Ca2+ and H+ in larval mosquito (Aedes aegypti) midgut epithelium in response to serosal serotonin and lumen pH. J Insect Physiol (2011) 0.76
The functional interaction between HMGA1 and the estrogen receptor requires either the N- or the C-terminal domain of the receptor. FEBS Lett (2004) 0.76
Activation of mammalian target of rapamycin contributes to pain nociception induced in rats by BmK I, a sodium channel-specific modulator. Neurosci Bull (2013) 0.76
Dominant-negative HMGA1 blocks mu enhancer activation through a novel mechanism. Biochem Biophys Res Commun (2002) 0.75
Increased plasma osteoprotegerin concentrations in Type 1 diabetes with albuminuria. Clin Nephrol (2013) 0.75
Crossover replantation after bilateral traumatic lower limb amputations: a case report. J Med Case Rep (2012) 0.75
Microglial activation of p38 contributes to scorpion envenomation-induced hyperalgesia. Biochem Biophys Res Commun (2013) 0.75
Combined use of regulatory elements within the cDNA to increase the production of a soluble mouse single-chain antibody, scFv, from tobacco cell suspension cultures. Protein Expr Purif (2002) 0.75
[Observation of Qigui Tongfengshu granules in treatment of sixteen cases of gouty arthritis]. Zhongguo Zhong Yao Za Zhi (2013) 0.75
New furanones from the plant endophytic fungus Pestalotiopsis besseyi. Molecules (2012) 0.75
Sinapyl alcohol derivatives from the lipo-soluble part of Dichrocephala benthamii C. B. Clarke. Molecules (2013) 0.75
Transformation of strictosamide to vincoside lactam by acid catalysis. Chin J Nat Med (2013) 0.75
Isolation, antimicrobial activity, and absolute configuration of the furylidene tetronic acid core of pestalotic acids A-G. Org Biomol Chem (2012) 0.75
[Relationship between proliferation of vascular smooth muscle cells and PDGF-AA and PDGFR-alpha expression in SHRs]. Sheng Li Xue Bao (2002) 0.75
[Quality evaluation of guizhi fuling capsule using self-control method of reference Chinese medicine preparation]. Zhongguo Zhong Yao Za Zhi (2014) 0.75
[The immunological characteristics of tonsil mesenchymal stem cells]. Zhonghua Zheng Xing Wai Ke Za Zhi (2015) 0.75
Two new derivatives of 2, 5-dihydroxyphenylacetic acid from the kernel of Entada phaseoloides. Molecules (2013) 0.75
A new dihydroagarofuranoid sesquiterpene from the roots of Tripterygium hypoglaucum. J Asian Nat Prod Res (2014) 0.75
[Orthogonal test for preparing genipin with enzymolyzed geniposide]. Zhongguo Zhong Yao Za Zhi (2012) 0.75
[Main progress on studies of pharmacological activities and clinical applications of Guizhi Fuling capsule]. Zhongguo Zhong Yao Za Zhi (2015) 0.75
In vivo anti-inflammatory and analgesic activities of strictosamide from Nauclea officinalis. Pharm Biol (2014) 0.75
[Quality evaluation of domestic Echinacea extracts]. Zhongguo Zhong Yao Za Zhi (2012) 0.75
[Experimental research about the effect of Rehmannia glutinosa on the drug effect fingerprints of the rabbit's blood serum of Yin deficiency and heat flourishing syndrome]. Zhong Yao Cai (2007) 0.75